Prognostic Genomic Biomarkers in Patients With Localized Prostate Cancer: Is Rising Utilization Justified by Evidence?
JAMA Oncol
.
2020 Nov 25.
doi: 10.1001/jamaoncol.2020.6045.
Online ahead of print.
Authors
Daniel W Lin
1
,
Peter S Nelson
2
Affiliations
1
Department of Urology, University of Washington, Seattle, Washington.
2
Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
PMID:
33237305
DOI:
10.1001/jamaoncol.2020.6045
No abstract available